Diabetes medications with cardiovascular protection in the wake of EXSCEL: Is there a class effect for long-acting GLP-1 receptor agonists?

Robert E.J. Ryder, Ralph A. Defronzo

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)131-133
Number of pages3
JournalBritish Journal of Diabetes and Vascular Disease
Issue number4
StatePublished - 2017

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this